Paloma Partners Management CO Cerus Corp Transaction History

Paloma Partners Management CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$5.35 - $6.35 $314,194 - $372,922	-58,728 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$5.68 - $7.87 $161,755 - $224,121	28,478 Added 94.14%	58,728 $353,000
Q4 2020 Feb 16, 2021	SELL	$5.25 - $8.56 $52,710 - $85,942	-10,040 Reduced 24.92%	30,250 $209,000
Q3 2020 Nov 16, 2020	BUY	$5.78 - $7.47 $232,876 - $300,966	40,290 New	40,290 $252,000
Q2 2020 Aug 14, 2020	SELL	$4.5 - $7.02 $116,554 - $181,825	-25,901 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$2.87 - $5.49 $74,335 - $142,196	25,901 New	25,901 $120,000
Q3 2018 Nov 14, 2018	SELL	$6.89 - $7.78 $154,708 - $174,692	-22,454 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$5.19 - $7.25 $116,536 - $162,791	22,454 New	22,454 $150,000

160

144M

22.5K

23.6K

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $328M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.